Business Wire

Continuous Protection for the Cloud Era: Veracode Spotlights Latest Innovations for Advanced Software Security

24.7.2025 13:50:00 CEST | Business Wire | Press Release

Share

Veracode, a global leader in application risk management, today unveiled a suite of innovations that transform how enterprises approach security. The enhanced platform cuts vulnerability remediation time by up to 92 percent, while using proactive defense to prevent 60 percent of critical supply chain risk from ever entering organizations. These latest enhancements to Veracode’s Package Firewall and Risk Manager provide assurance, context, and continuity across the software development lifecycle.

“Security teams tell us they’re drowning in vulnerability alerts while missing the risks that actually matter. Our latest innovations flip the script—instead of endless firefighting, teams can now prevent threats proactively and focus remediation efforts where they’ll have maximum business impact,” said Derek Maki, Head of Product at Veracode.

Redefining Application Risk Management with End-to-End Risk Visibility

The latest enhancements to Veracode’s Application Risk Management platform enable security teams to identify and remediate vulnerabilities with greater speed and precision than ever before. Veracode Risk Manager sets a new standard for application security posture management (ASPM), featuring six new integrations with industry leaders, including Wiz. By aggregating and prioritizing issues across all sources, Risk Manager reduces vulnerability remediation time by up to 92 percent. This holistic view empowers security teams to act on the Best Next Action™—the actions that reduce the most risk—with precision.

Securing the Software Supply Chain

With 70 percent of critical security debt stemming from third-party code, enterprises are under unprecedented pressure to safeguard their software supply chains. Regulations like the European Union’s Digital Operational Resilience Act (DORA) highlight the vital role of open-source security in maintaining software supply chain integrity.

Veracode Package Firewall redefines supply chain security with an automated solution that blocks untrusted packages, before they can infiltrate development pipelines. Powered by advanced AI analysis, Package Firewall identifies and blocks 60 percent more malicious packages than competing solutions, effectively preventing vulnerabilities, malware, and policy violations from entering organizational systems.

Paired with Software Composition Analysis (SCA) and Malicious Package Detection, Veracode Package Firewall significantly reduces the risk of supply chain attacks by finding and neutralizing libraries harboring malicious code.

“Veracode Package Firewall represents a fundamental shift in how we think about supply chain security. While others are still alerting malicious packages after they’re in your codebase, we’re blocking them at the gate. This means security teams can finally get ahead of supply chain threats instead of scrambling to respond when legitimate packages get compromised or malicious packages slip through,” said Maki.

Built on proprietary threat intelligence, the product automates real-time risk management to ensure nefarious files and programs never make it into an organization’s codebase.

Empowering Developer Productivity with Frictionless Security

According to Gartner, Inc., organizations with a high-quality developer experience are 33 percent more likely to attain their business goals and 31 percent more likely to improve delivery flow. Veracode continues to champion developer productivity through an enhanced platform experience, featuring improved Integrated Developer Environment (IDE) plugins and new Git integrations that embed enterprise-level security directly into workflows.

“Developer productivity isn’t just a nice-to-have; it directly impacts your ability to ship secure software at market speed. Our IDE integrations deliver enterprise-grade security insights without the context switching that kills developer flow. This is why we’re seeing 35 percent faster remediation times with our IDE plugins and integrations, including Visual Studio, IntelliJ IDEA, and Eclipse, as well as GitHub, GitLab, and Azure DevOps,” said Maki.

Veracode’s latest developer-focused innovations eliminate operational inefficiencies and simplify workflows, removing unnecessary complexity from day-to-day DevSecOps processes. Additional innovations include:

  • AI-Assisted Login for Dynamic Application Security Testing (DAST): Automates complex authentication flows, reducing script setup time by 50 percent and expanding dynamic testing coverage.
  • Container and Infrastructure-as-Code (IaC) Results: Centralizes container and IaC findings in the Veracode Platform, streamlining vulnerability management.
  • Veracode Fix Usage Analytics: Provides a dashboard that tracks usage and Common Weakness Enumerations (CWEs) addressed, offering insights by IDE, project, and source file to optimize remediation.

Availability

Veracode’s latest product innovations are available to customers today. To find out more about the company’s application risk management platform and solutions, visit the website.

About Veracode

Veracode is a global leader in Application Risk Management for the AI era. Powered by trillions of lines of code scans and a proprietary AI-assisted remediation engine, the Veracode platform is trusted by organizations worldwide to build and maintain secure software from code creation to cloud deployment. Thousands of the world’s leading development and security teams use Veracode every second of every day to get accurate, actionable visibility of exploitable risk, achieve real-time vulnerability remediation, and reduce their security debt at scale. Veracode is a multi-award-winning company offering capabilities to secure the entire software development life cycle, including Veracode Fix, Static Analysis, Dynamic Analysis, Software Composition Analysis, Container Security, Application Security Posture Management, Malicious Package Detection, and Penetration Testing.

Learn more at www.veracode.com, on the Veracode blog, and on LinkedIn and X.

Copyright © 2025 Veracode, Inc. All rights reserved. Veracode is a registered trademark of Veracode, Inc. in the United States and may be registered in certain other jurisdictions. All other product names, brands, or logos belong to their respective holders. All other trademarks cited herein are property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250724023276/en/

Contacts

Press and Media:
Katy Gwilliam
Head of Global Communications, Veracode
kgwilliam@veracode.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye